472 related articles for article (PubMed ID: 30741348)
21. Identifying patients at risk for recurrent or advanced BCC.
Hamid O; Goldenberg G
J Drugs Dermatol; 2013 Nov; 12(11):1246-52; quiz 1253-4. PubMed ID: 24196332
[TBL] [Abstract][Full Text] [Related]
22. Before or after: is there a connection between the use of adjunctive nonmelanoma skin cancer treatments and subsequent invasive tumors?
Ruiz ES; Cohen JL; Friedman A
J Drugs Dermatol; 2015 May; 14(5):450-2. PubMed ID: 25942661
[TBL] [Abstract][Full Text] [Related]
23. Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial.
Arits AH; Mosterd K; Essers BA; Spoorenberg E; Sommer A; De Rooij MJ; van Pelt HP; Quaedvlieg PJ; Krekels GA; van Neer PA; Rijzewijk JJ; van Geest AJ; Steijlen PM; Nelemans PJ; Kelleners-Smeets NW
Lancet Oncol; 2013 Jun; 14(7):647-54. PubMed ID: 23683751
[TBL] [Abstract][Full Text] [Related]
24. Current Basal and Squamous Cell Skin Cancer Management.
Mendez BM; Thornton JF
Plast Reconstr Surg; 2018 Sep; 142(3):373e-387e. PubMed ID: 30148788
[TBL] [Abstract][Full Text] [Related]
25. European consensus-based interdisciplinary guideline for diagnosis and treatment of basal cell carcinoma-update 2023.
Peris K; Fargnoli MC; Kaufmann R; Arenberger P; Bastholt L; Seguin NB; Bataille V; Brochez L; Del Marmol V; Dummer R; Forsea AM; Gaudy-Marqueste C; Harwood CA; Hauschild A; Höller C; Kandolf L; Kellerners-Smeets NWJ; Lallas A; Leiter U; Malvehy J; Marinović B; Mijuskovic Z; Moreno-Ramirez D; Nagore E; Nathan P; Stratigos AJ; Stockfleth E; Tagliaferri L; Trakatelli M; Vieira R; Zalaudek I; Garbe C;
Eur J Cancer; 2023 Oct; 192():113254. PubMed ID: 37604067
[TBL] [Abstract][Full Text] [Related]
26. Current diagnosis and treatment of basal cell carcinoma.
Alter M; Hillen U; Leiter U; Sachse M; Gutzmer R
J Dtsch Dermatol Ges; 2015 Sep; 13(9):863-74; quiz 875. PubMed ID: 26882375
[TBL] [Abstract][Full Text] [Related]
27. Basal Cell Carcinoma.
Heath MS; Bar A
Dermatol Clin; 2023 Jan; 41(1):13-21. PubMed ID: 36410973
[TBL] [Abstract][Full Text] [Related]
28. Management of nonmelanoma skin cancer in 2007.
Neville JA; Welch E; Leffell DJ
Nat Clin Pract Oncol; 2007 Aug; 4(8):462-9. PubMed ID: 17657251
[TBL] [Abstract][Full Text] [Related]
29. Diagnosis and treatment of basal cell and squamous cell carcinomas.
Stulberg DL; Crandell B; Fawcett RS
Am Fam Physician; 2004 Oct; 70(8):1481-8. PubMed ID: 15526735
[TBL] [Abstract][Full Text] [Related]
30. Variations in clinical presentation of basal cell carcinoma.
Buljan M; Bulat V; Situm M; Mihić LL; Stanić-Duktaj S
Acta Clin Croat; 2008 Mar; 47(1):25-30. PubMed ID: 18714644
[TBL] [Abstract][Full Text] [Related]
31. [Diagnosis and treatment of basal cell carcinoma : A question of the risk of recurrence].
Lang BM; Grabbe S
Hautarzt; 2020 Aug; 71(8):580-587. PubMed ID: 32533202
[TBL] [Abstract][Full Text] [Related]
32. Large facial basal cell carcinoma treated with multimodal combination therapy.
Rubenzik MK; Schwartz LR; Humphreys TR
Cutis; 2011 Oct; 88(4):182-4. PubMed ID: 22106726
[TBL] [Abstract][Full Text] [Related]
33. Diagnosis and treatment of Basal cell and squamous cell carcinoma.
Firnhaber JM
Am Fam Physician; 2012 Jul; 86(2):161-8. PubMed ID: 22962928
[TBL] [Abstract][Full Text] [Related]
34. Guidelines of care for the management of basal cell carcinoma.
; ; Kim JYS; Kozlow JH; Mittal B; Moyer J; Olencki T; Rodgers P
J Am Acad Dermatol; 2018 Mar; 78(3):540-559. PubMed ID: 29331385
[TBL] [Abstract][Full Text] [Related]
35. A systematic review of treatment modalities for primary basal cell carcinomas.
Thissen MR; Neumann MH; Schouten LJ
Arch Dermatol; 1999 Oct; 135(10):1177-83. PubMed ID: 10522664
[TBL] [Abstract][Full Text] [Related]
36. [Basal cell carcinoma].
Takenouchi T
Gan To Kagaku Ryoho; 2006 Oct; 33(10):1398-403. PubMed ID: 17033227
[TBL] [Abstract][Full Text] [Related]
37. Management of high-risk and advanced basal cell carcinoma.
Puig S; Berrocal A
Clin Transl Oncol; 2015 Jul; 17(7):497-503. PubMed ID: 25643667
[TBL] [Abstract][Full Text] [Related]
38. Update of the European guidelines for basal cell carcinoma management.
Trakatelli M; Morton C; Nagore E; Ulrich C; Del Marmol V; Peris K; Basset-Seguin N;
Eur J Dermatol; 2014; 24(3):312-29. PubMed ID: 24723647
[TBL] [Abstract][Full Text] [Related]
39. New treatment modalities for basal cell carcinoma.
Stockfleth E; Sterry W
Recent Results Cancer Res; 2002; 160():259-68. PubMed ID: 12079222
[TBL] [Abstract][Full Text] [Related]
40. Emerging trends in the treatment of advanced basal cell carcinoma.
Migden MR; Chang ALS; Dirix L; Stratigos AJ; Lear JT
Cancer Treat Rev; 2018 Mar; 64():1-10. PubMed ID: 29407368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
